Domenighetti G, Leuenberger P, Perret C
Schweiz Med Wochenschr. 1985 Jan 19;115(3):99-103.
The hemodynamic and respiratory effects of phentolamine i.v. (15-30 mg/h) on pulmonary hypertension following chronic obstructive pulmonary disease (COPD) have been studied in 13 patients under stable conditions. Phentolamine produced a significant reduction in mean pulmonary arterial pressure, right and left ventricular filling pressures and right ventricular stroke work index. Cardiac index and oxygen delivery increased significantly. Individual analysis showed that in 7 patients the driving pressure decreased across the pulmonary circulation with concomitant increase in cardiac output, suggesting a direct vasodilating effect of phentolamine on the pulmonary circulation. Pulmonary gas exchange did not change significantly. In conclusion, in patients with pulmonary hypertension following COPD phentolamine given i.v. may have beneficial effects on right ventricular function and peripheral oxygen delivery without detrimental effect on gas exchange.
在13例病情稳定的慢性阻塞性肺疾病(COPD)患者中,研究了静脉注射酚妥拉明(15 - 30毫克/小时)对肺动脉高压的血流动力学和呼吸效应。酚妥拉明可使平均肺动脉压、左右心室充盈压及右心室每搏作功指数显著降低。心指数和氧输送量显著增加。个体分析显示,7例患者肺循环驱动压降低,同时心输出量增加,提示酚妥拉明对肺循环有直接血管舒张作用。肺气体交换无显著变化。总之,对于COPD所致肺动脉高压患者,静脉注射酚妥拉明可能对右心室功能和外周氧输送有益,而对气体交换无不利影响。